The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
Abstract
BACKGROUND: Serotype 19A invasive pneumococcal disease (IPD) increased annually in the United States after the introduction of the 7-valent conjugate vaccine (PCV7). To understand this increase, we characterized serotype 19A isolates recovered during 2005. METHODS: IPD cases during 1998-2005 were identified through population-based surveillance. We performed susceptibility testing and multilocus sequence typing on 528 (95%) of 554 serotype 19A isolates reported in 2005. RESULTS: The incidence of IPD due to serotype 19A increased from 0.8 to 2.5 cases per 100,000 population between 1998 and 2005 (P < .05), whereas the overall incidence of IPD decreased from 24.4 to 13.8 cases per 100,000 population (P < .05). Simultaneously, the incidence of IPD due to penicillin-resistant 19A isolates increased from 6.7% to 35% (P < .0001). Of 151 penicillin-resistant 19A isolates, 111 (73.5%) belonged to the rapidly emerging clonal complex 320, which is related to multidrug-resistant Taiwan(19F)-14. The remaining penicillin-resistant strains were highly related to other clones of PCV7 serotypes or to isolates within major 19A clonal complex 199 (CC199). In 1999, only CC199 and 3 minor clones were apparent among serotype 19A isolates. During 2005, 11 multiple-isolate clonal sets were detected, including capsular switch variants of a serotype 4 clone. CONCLUSIONS: PCV7 ineffectiveness against serotype 19A, antibiotic resistance, clonal expansion and emergence, and capsular switching have contributed to the genetic diversity of 19A and to its emergence as the predominant invasive pneumococcal serotype in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Self-citationFeil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., & Spratt, B. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1518-1530.2004 · Cited by 1,861
Enright, M. C., & Spratt, B. G. (1998) · Microbiology · doi:10.1099/00221287-144-11-3049 · Cited by 1,074
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Self-citationLexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Self-citationWhitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Self-citationBrueggemann, A. B., Griffiths, D. T., Meats, E., Peto, T., Crook, D. W., & Spratt, B. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374624 · Cited by 619
Self-citationSingleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K., & Parkinson, A. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615
Cited by
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationGuidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Rapid Pneumococcal Evolution in Response to Clinical Interventions
Croucher, N. J., Harris, S. R., Fraser, C., Quail, M. A., Burton, J., van der Linden, M., McGee, L., von Gottberg, A., Song, J. H., Ko, K. S., et al. (2011) · Science · doi:10.1126/science.1198545 · Cited by 886
Self-citationMiller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings
Grijalva, C. G. (2009) · JAMA · doi:10.1001/jama.2009.1163 · Cited by 513
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Guidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Mechanisms of microbial traversal of the blood–brain barrier
Kim, K. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1952 · Cited by 466
Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity
Samai, P., Pyenson, N., Jiang, W., Goldberg, G. W., Hatoum-Aslan, A., & Marraffini, L. A. (2015) · Cell · doi:10.1016/j.cell.2015.04.027 · Cited by 426
Population genomics of post-vaccine changes in pneumococcal epidemiology
Croucher, N. J., Finkelstein, J. A., Pelton, S. I., Mitchell, P. K., Lee, G. M., Parkhill, J., Bentley, S. D., Hanage, W. P., & Lipsitch, M. (2013) · Nature Genetics · doi:10.1038/ng.2625 · Cited by 365
Kim, S. H., Song, J.-H., Chung, D. R., Thamlikitkul, V., Yang, Y., Wang, H., Lu, M., So, T. M.-K., Hsueh, P.-R., Yasin, R. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05658-11 · Cited by 341
Liñares, J., Ardanuy, C., Pallares, R., & Fenoll, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03182.x · Cited by 323
Bikard, D., Hatoum-Aslan, A., Mucida, D., & Marraffini, L. A. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.003 · Cited by 318
Harboe, Z. B., Dalby, T., Weinberger, D. M., Benfield, T., Mølbak, K., Slotved, H. C., Suppli, C. H., Konradsen, H. B., & Valentiner-Branth, P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu524 · Cited by 313
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296
Self-citationLo, S. W., Gladstone, R. A., van Tonder, A. J., Lees, J. A., du Plessis, M., Benisty, R., Givon-Lavi, N., Hawkins, P. A., Cornick, J. E., Kwambana-Adams, B., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30297-x · Cited by 291
Self-citationKim, L., McGee, L., Tomczyk, S., & Beall, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-15 · Cited by 285
Self-citationLynch, J. P., & Zhanel, G. G. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283385653 · Cited by 271
Vesikari, T., Wysocki, J., Chevallier, B., Karvonen, A., Czajka, H., Arsène, J.-P., Lommel, P., Dieussaert, I., & Schuerman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318199f8ef · Cited by 268
Casado-Flores, J., Rodrigo, C., Arístegui, J., Martínón, J. M., Fenoll, A., & Mendez, C. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817bd2dc · Cited by 47
Metadata
- Authors
- Moore, M. R., Gertz, Jr., Woodbury, R. L., Barkocy‐Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M., Harrison, L. H., Hadler, J. L., Bennett, N. M., Thomas, A. R., McGee, L., Pilishvili, T., Brueggemann, A. B., Whitney, C. G., Jorgensen, J. H., & Beall, B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04
- Volume
- 197
- Issue
- 7
- Pages
- 1016-1027
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2156956165
- Cited by
- 480
- References
- 31
- FWCI
- 43.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.